Page last updated: 2024-12-06

propamidine isethionate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Propamidine isethionate is a synthetic diamidine compound that has been used as an antimicrobial agent since the 1950s. It is effective against a wide range of microorganisms, including bacteria, fungi, and protozoa. The compound works by binding to DNA and inhibiting the synthesis of nucleic acids, leading to cell death. Propamidine isethionate is typically used topically to treat skin and eye infections, and it is also used as a preservative in ophthalmic solutions and other pharmaceutical preparations. The compound has been studied extensively for its potential therapeutic uses, including the treatment of African trypanosomiasis, leishmaniasis, and other parasitic diseases. Research continues to explore its potential against new pathogens, such as multidrug-resistant bacteria and parasites. While it is generally considered safe for topical use, propamidine isethionate can cause side effects such as skin irritation, redness, and itching. It is important to consult with a healthcare professional before using this compound, especially if you have any pre-existing conditions or are pregnant or breastfeeding.'

propamidine isethionate : A guanidinium salt obtained by combining propamidine with two molar equivalents of isethionic acid. Used for the treatment of minor eye or eyelid infections, such as conjunctivitis and blepharitis. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID67413
CHEBI ID87175
MeSH IDM0135077

Synonyms (25)

Synonym
einecs 205-423-6
propamidine isetionate
m + b 782
propamidine diisethionate
m&b 782
propamidine isthionate
propamidine isethionate
140-63-6
D08436
golden eye drops (tn)
7t9ij84c42 ,
unii-7t9ij84c42
propamidine isethionate [mi]
propamidine isetionate [mart.]
benzamidine, 4,4'-(trimethylenedioxy)di-, bis(2-hydroxyethanesulfonate)
m&b-782
brolene drops
propamidine isetionate [who-dd]
[propane-1,3-diylbis(oxy-4,1-phenylene)]bis(iminomethanaminium) bis(2-hydroxyethane-1-sulfonate)
golden eye drops
2-hydroxyethane-1-sulfonic acid--4,4'-[propane-1,3-diylbis(oxy)]di(benzene-1-carboximidamide) (2/1)
CHEBI:87175
DTXSID50161211
propamidine diisetionate
Q27159426

Research Excerpts

Overview

Propamidine isethionate and neomycin are an effective treatment for Acanthamoeba keratitis.

ExcerptReferenceRelevance
"Propamidine isethionate and neomycin are an effective treatment for Acanthamoeba keratitis. "( Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis. Brolene Study Group.
Hargrave, SL; Husseini, Z; McCulley, JP, 1999
)
2.03

Toxicity

ExcerptReferenceRelevance
" The aim of this study was to determine the toxic profile of chlorhexidine and propamidine eye drops."( In Vitro Evaluation of the Ophthalmic Toxicity Profile of Chlorhexidine and Propamidine Isethionate Eye Drops.
Díaz-Tome, V; Fernández-Ferreiro, A; Gil-Martínez, M; González-Barcia, M; Lamas, MJ; Luaces-Rodríguez, A; Méndez, JB; Otero-Espinar, FJ; Pardo, M; Piñeiro-Ces, A; Rodríguez-Ares, MT; Santiago-Varela, M, 2017
)
0.68
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antimicrobial agentA substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
antiseptic drugA substance used locally on humans and other animals to destroy harmful microorganisms or to inhibit their activity (cf. disinfectants, which destroy microorganisms found on non-living objects, and antibiotics, which can be transported through the lymphatic system to destroy bacteria within the body).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
guanidinium saltAn organic salt in which the cation has the structure (RN)2C=N(+)R2.
organosulfonate saltAny organic salt prepared using an organosulfonic acid as the acid component.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (60)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (13.33)18.7374
1990's20 (33.33)18.2507
2000's14 (23.33)29.6817
2010's15 (25.00)24.3611
2020's3 (5.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.96 (24.57)
Research Supply Index4.16 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index67.96 (26.88)
Search Engine Supply Index3.09 (0.95)

This Compound (33.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.61%)5.53%
Reviews3 (4.84%)6.00%
Case Studies32 (51.61%)4.05%
Observational0 (0.00%)0.25%
Other26 (41.94%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]